Effects of long-term treatment with proton pump inhibitors in gastrooesophageal reflux disease on the histological findings in the lower oesophagus

Scandinavian Journal of Gastroenterology

Volumn 35, Issue 11, 2000, Pages 1125-1130

  Stolte, M ^a   Vieth, M ^a   Schmitz, J M ^a   Alexandridis, T ^a   Seifer, E ^a  

^a INSTITUTE OF PATHOLOGY   (Germany)

Author keywords

Gastro oesophageal reflux disease; Proton pump inhibitors

Indexed keywords

LANSOPRAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR;

ARTICLE; BASAL CELL; CELL HYPERPLASIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EROSION; ESOPHAGUS MUCOSA; GASTROESOPHAGEAL REFLUX; HUMAN; LONG TERM CARE; LOWER ESOPHAGUS SPHINCTER; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS EPITHELIUM; ULCER;

EID: 0033637030     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655200750056574     Document Type: Article

References (43)

1. When is esophagitis healed? Esophageal endoscopy, histology and function before and after cimetidine treatment
2. The normal human esophageal mucosa: A histological reappraisal
3. Comparison of omeprazole and cimetidine in reflux esophagitis: Symptomatic, endoscopic, and histological evaluations
4. Therapy and prevention of reflux esophagitis. Results of a multicenter study with cimetidine. I. Epidemiology and results of acute therapy
5. Diagnostic value of histology in non-erosive gastro-oesophageal reflux disease
6. Vergleichende untersuchung der wirkung von lansoprazol und ranitidin auf die abheilung der akuten refluxosophagitis
7. Lansoprazole maintains healing in patients with reflux esophagitis
8. Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings
9. A comparative cytopathologic and histologic study of atypia, dysplasia, and adenocarcinoma in Barrett's esophagus
10. Incidence of cancer of the esophagus in the US by histologic type
11. Distribution of the histological changes of gastroesophageal reflux in the distal esophagus of man
12. Histological consequences of gastroesophageal reflux in man
13. Omeprazole and ranitidine in treatment of reflux-oesophagitis: Double blind comparative trial
14. Treatment of childhood peptic oesophagitis with famotidine or alginat-antacid
15. Role of gastric acid suppression in the treatment of gastroesophageal reflux disease
16. Omeprazole or ranitidine in long-term treatment of reflux esophagitis
17. Double blind comparison of omeprazole (40 mg od) versus cimetidine in the treatment of symptomatic erosive reflux oesophagitis, assessed endoscopically, histologically and by 24 h pH monitoring
18. A comparison esophageal stricture
19. Double-blind study of pantoprazole and omeprazole in the treatment of reflux oesophagitis: A multicentre trial
20. Appropriate acid suppression for optimal healing of duodenal ulcer and gastrooesophageal reflux disease
21. Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: The U.S. multicenter study
22. Prevalence of metaplasia at the gastro-oesophageal junction
23. Diagnostic inconsistencies in Barrett's esophagus
24. Mechanisms of lower esophageal sphincter incompetence in patients with symptomatic gastroesophageal reflux
25. Reflux esophagitis: Overview
26. Mechanisms of gastroesophageal reflux in ambulant healthy human subjects
27. Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux oesophagitis
28. Reflux oesophagifis resolves more rapidly with omeprazole 20 mg once daily than with ranitidine 150 mg twice daily: Omeprazole 40 mg once daily provides further benefit in unresponsive patients
29. Comparison of omeprazole and ranitidine in treatment of refractory gastroesophageal reflux disease in patients with gastric acid hypersecretion
30. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: A metaanalysis
31. Prospective evaluation of omeprazole treatment in reflux oesophagitis refractory to H2-receptor antagonists
32. Comparative trial of pantoprazole and ranitidine in the treatment of reflux esophagitis. Results of a German multicentre study
33. Long-term maintenance treatment of reflux esophagitis with omeprazole. Prospective study in patients with H2-blocker-resistant esophagitis
34. 24-Hour intragastric acidity and plasma gastrin during long-term treatment with omeprazole or ranitidine in patients with reflux esophagitis
35. Prevention of relapse of reflux esophagitis after endoscopic healing: The efficacy and safety of omeprazole compared with ranitidine
36. Omeprazole or high-dose ranitidine in the treatment of patients with reflux oesophagitis not responding to 'standard doses' of H2-receptor antagonists
37. Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis
38. The effect of omeprazole or ranitidine treatment on 24-hour esophageal acidity in patients with reflux esophagitis
39. A comparison of five maintenance therapies for reflux esophagitis
40. Morphometric assessment of reflux oesophagitis in fiberoptic biopsy specimens
41. Vascular changes in the esophageal mucosa. An early histologic sign of esophagitis
42. Endoscopic and biopsy criteria for the diagnosis of esophagitis with a fiberoptic esophagoscope
43. Microvascular lesions in reflux oesophagitis and Barrett's oesophagus